Invention Grant
- Patent Title: Preservative-free treprostinil devices
-
Application No.: US16828145Application Date: 2020-03-24
-
Publication No.: US11318148B2Publication Date: 2022-05-03
- Inventor: Jonathan Rigby , Peter Noymer , Robert Zwolinski
- Applicant: SteadyMed, Ltd.
- Assignee: SteadyMed, Ltd.
- Current Assignee: SteadyMed, Ltd.
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K31/5575
- IPC: A61K31/5575 ; A61K9/00 ; A61M5/142 ; C07C39/17 ; C07C59/72 ; C07C405/00

Abstract:
Embodiments include a system including a sealed prefilled drug-reservoir. The drug-reservoir may include a unit dosage of treprostinil in a sterile fluid composition. The composition may not include an antimicrobial preservative. The treprostinil may be present at a dosage of between 0.1 mg/mL and 25 mg/mL. In addition, the treprostinil may be treprostinil sodium Furthermore, the composition may include sodium chloride. The composition may also include a sodium ion from sodium chloride in a concentration from 3000 to 4500 ppm. The composition may not include metacresol.
Public/Granted literature
- US20200237780A1 Preservative-free Treprostinil Devices Public/Granted day:2020-07-30
Information query